BioAge Announces Indication Expansion for Oral NLRP3 Inhibitor BGE-102, with Plans to Initiate Phase 1b/2a Proof-of-Concept Clinical Trial in Patients with Diabetic Macular Edema in Mid-2026

Analysts Offer Insights on Healthcare Companies: Shionogi & Co (OtherSGIOF), Johnson & Johnson (JNJ) and CVS Health (CVS)

Jefferies Keeps Their Buy Rating on Alfa SAB de CV (ALFFF)

Shaw and Partners Reaffirms Their Buy Rating on CV Check Ltd (KYP)

ZF Commercial Vehicle Systems Says Harman ADAS Deal Will Not Affect Its India CV Business

Kinatico lifts SaaS revenue 42% as compliance platform gains traction

UBS Upgrades Vista Energy SAB de CV to Buy From Neutral, Adjusts Price Target to $65 From $50

Esperion Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization

Volaris Ends 2025 With Higher Traffic But Lower Load Factor in December

CapsoVision Is Maintained at Speculative Buy by Benchmark

Capsovision Inc : Benchmark Raises Target Price to $14 From $5

U.S. RESEARCH ROUNDUP-Nextera Energy, Nextpower, TKO Group

CapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera

CapsoVision Submits 510(k) Application for AI-Assisted Capsule Endoscopy Module

U.S. Deploys Additional Special Operations Aircraft and Troops to the Caribbean

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:55 PM

Lithium Carbonate Target Price Raised to $18,000! JPMorgan Bullish on Lithium, Upgrades All Pure Lithium Miners to "Overweight"

Pudong's New AI Policy Unleashes Development Potential: Badou Academy Bridges Talent Training with Industry Needs